NCT00853294 - Fasting Study of Chlorpheniramine Polistirex and Hydrocodone Polistirex Capsules and Tussionex® Pennkinetic® Extended Release Oral Suspension | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

September 30, 2003

Study Completion Date

September 30, 2003

Conditions

Healthy

Interventions

DRUG

Chlorpheniramine polistirex equivalent to 8 mg of chlorpheniramine maleate and hydrocodone polistirex equivalent to 10 mg of hydrocodone bitartrate capsule

Chlorpheniramine polistirex/hydrocodone polistirex extended release capsule, single dose fasting

DRUG

5 mL chlorpheniramine (8 mg/5 mL)/hydrocodone (10 mg/5 mL) extended release oral suspension

Tussionex® Pennkinetic® Extended Release Oral Suspension, single dose fasting